Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2026-03-02 @ 4:09 AM
Study NCT ID:
NCT00516893
Status:
COMPLETED
Last Update Posted:
2014-05-15
First Post:
2007-08-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Natalizumab High Titer Immunogenicity and Safety
Sponsor:
Organization: